A Phase III Study of Docetaxel and S-1 versus S-1 in the Treatment of Advanced Gastric Cancer
Phase of Trial: Phase III
Latest Information Update: 21 Jan 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Docetaxel
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms START
- 21 Jan 2017 Results (n=1248) of a combined analysis from SPIRITS, TOP-002 and START trials, presented at the 2017 Gastrointestinal Cancers Symposium
- 02 Oct 2012 Results of the updated analysis presented at the 37th Congress of the European Society for Medical Oncology.
- 07 Jun 2011 Updated results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.